NEW INTERNATIONAL SALES APPOINTMENTS TO COMPUMEDICS LTD
Tim Gresham appointed Business Director, Asia and South America, Ben So appointed Senior Business Manager, Asia.
Tim Gresham appointed Business Director, Asia and South America, Compumedics Ltd
Melbourne, Australia – for immediate release, July 15th, 2005 – David Burton, Chairman of the Board and Chief Executive Officer of Compumedics Limited (ASX:CMP), today announced that Tim Gresham has joined Compumedics Ltd as Business Director, Asia and South America. Asia represents one of the most exciting medical-device growth-market opportunities for Compumedics, particularly considering the significant growth outlook for regions such as China, Japan and Korea. Tim will be reporting to the CEO. In this position, Tim will be responsible for all Compumedics sales in the prescribed area. He will be tasked with achieving specific sales goals and will provide strategic management of the regions, professional guidance on our developing Sales and Marketing Systems and Processes, support for distributors and leadership for his direct reports. Tim will be a welcome addition to the Compumedics Ltd management team and most importantly, enhance, drive and focus upon our Asia growth performance.
Tim comes with an impressive educational background of Technical Life Sciences and Business Management. He has a BSc and an MBA. He spent 8 years in various capacities with Abbott Laboratories in their Australian operation. He has worked in sales and marketing capacities covering a wide variety of health-care applications from anti-infectives and hormone replacement to HIV medicine, hepatitis diagnostics and endocrinology.
His work with health authorities and Abbott’s large corporate customers has seen him become one of Abbott Australia’s most highly awarded managers. Tim left Abbott at the end of 2000 to embark on an MBA in Dublin, relocating his family to Europe. Immediately following the MBA Tim spearheaded the marketing strategy for a small UK-based monitoring company, Deltex Medical, enhancing sales efforts in existing markets and continuing the march into high potential growth regions across the globe. Tim has spent the last two years with VIASYS Healthcare as Business Director Asia Pacific. In this time he developed and executed a comprehensive plan for investment and business development in China and grew business in the other Asia Pacific countries by an average of 25%.
Tim resides in Australia and will travel extensively in his assigned areas.
Ben So appointed Senior Business Manager, Asia Compumedics Ltd
David Burton is further delighted to announce that Ben So has joined Compumedics Ltd as Senior Business Manager, Asia. Ben will be reporting to Tim Gresham, Business Director, Asia and South America. In this position, Ben will be responsible for Compumedics sales in his prescribed area. He will be tasked with achieving specific sales goals and will provide guidance, sales leadership, training and support for distributors and his colleagues. Ben will be a key member of the Asia Pacific Team and Compumedics Ltd.
Originally an electrical engineer, Ben also comes to Compumedics from VIASYS Healthcare/Nicolet Biomedical and brings over 20 years’ experience in business development and leadership in Medical and Life Science corporations. He has Sales, Business Development and General Management experience in Neurological Diagnostics, Medical Equipment, Bio-Medical and Life Science industries.
Ben has spent the last 13 years developing an industry-leading Distribution Network across Asia Pacific for Nicolet Biomedical with lines of business including: EP/ EMG, IOM, EEG, ENG, Sleep Diagnostics, TCD and Auditory Diagnostics.
He resides on territory in Hong Kong.
We welcome both Tim and Ben to Compumedics, particularly as Compumedics continues to reinforce its world-wide business drive and performance.
Compumedics was founded in 1987 by current Executive Chairman and CEO, David Burton. In that year it established Australia’s first fully computerised sleep diagnostics clinic at Melbourne’s Epworth Hospital. In 1995 the company was selected to supply equipment to the US Sleep Heart Health Study, the world’s largest sleep study of its kind, currently exceeding 12,000 studies with 20,000 patients scheduled by 2008.
In 2002, the Company acquired US-based Neuroscan, boosting its presence in the neuro-diagnostics market, where the company supplies EEG and EMG devices to study electrical activity in the brain, spinal cord, nerves and muscles in the diagnosis and monitoring of neurological-based diseases.
In 2004, Compumedics acquired German based DWL, enabling Compumedics to expand its global operations into the neuro-vascular and cardio-vascular diagnostic arenas.
Since the 2000 financial year, the company has increased sales four-fold, reflecting product development initiatives combined with a strong United States distribution network, which accounts for 55% of sales.
The company’s core sleep-diagnostics technology is now being leveraged into the associated fields of neuro-diagnostics, brain research and blood-flow measurement. Combined, these markets have annual sales of more than USD900m. Compumedics also has businesses in supplies, technical service and educational services. Compumedics equipment is distributed in 60 countries globally. Headquarters are in Melbourne, Australia with offices in Germany, Singapore, Japan and the USA. Additional information can be obtained by visiting our website atwww.compumedics.com
Chief Executive Officer
Ph: + 61 3 8420 7300
Chief Financial Officer & Company Secretary
Ph: + 1 915 225 0319